The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | Trial updates at ASCO GI 2021
Ghassan Abou-Alfa, MD, Memorial Sloan-Kettering Cancer Center, New York City, NY, discusses the virtual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium and key updates presented at the meeting, including the long-term results of CheckMate 040, a Phase III study evaluating nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
